Why Blue Shield of California Ditching CVS Could Upend Drug Plans

“The decision was partly driven by CVS’ hesitancy earlier this year to cover a cheaper generic version of Johnson & Johnson’s prostate cancer drug Zytiga……”

Blue Shield of California may have upended the status quo for prescription drug plans on Thursday by dropping CVS Caremark as its sole pharmacy benefit manager and shifting some business to Amazon and Mark Cuban’s drug company.

Why Blue Shield of California ditching CVS could upend drug plans nationwide (axios.com)